Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia

Mayo Clinic Proceedings

Volumn 74, Issue 4, 1999, Pages 385-398

  Bennett, Robertm ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE;

FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; NEUROBIOLOGY; NOCICEPTION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; REVIEW; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032910403     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.4.385     Document Type: Review

References (180)

1. Croft P, Rigby AS, Boswell R, Scholium J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993:20:710-713
2. Croft P, Scholium J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309:696699
3. Wolfe F, Ross K, Anderson J, Russell U, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28
4. Andersson Hl, Ejlertsson G, Leden l, Rosenberg C. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain 1993:9:174-182
5. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997:70:3-14
6. MacFarlane GJ, Thomas E, Papageorgiou AC, Scholium J, Croft PR, Silman AJ. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 1996:23:16171620
7. Clauw DJ. Fibromyalgia: more than just a musculoskeletal disease [published erratum appears in Am Fam Physician 1996:54:1896; 1901-1902]. Am Fam Physician 1995:52:843-851; 853-854
8. Merskey H, Bogduk N, editors. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle: IASP Press; 1994. pp 210-211
9. Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM. Clinical characteristics of fibrositis. I. A blinded, controlled study of symptoms and tender points. Arthritis Rheum 1983;26:817-824
10. Atkins CJ, Zielinski A, Makosinski A. Palpometry: a novel concept in pain measurement. Nat Med 1995;1:1138-1139
11. Bendtsen L, Norregaard J, Jensen R, Olesen J. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 1997;40:98-102
12. Foreman RD, Schmidt RF, Willis WD. Effects of mechanical and chemical stimulation of fine muscle afférents upon primate spinothalamic tract cells. J Physiol (Lond) 1979;286:215-231
13. Yu XM, Mense S. Response properties and descending control of rat dorsal horn neurons with deep receptive fields. Neuroscience 1990:39:823-831
14. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996; 68:375-383
15. Dohrenbusch R, Sodhi H, Lamprecht J, Genth E. Fibromyalgia as a disorder of perceptual organization? An analysis of acoustic stimulus processing in patients with widespread pain. Z Rheumatol 1997:56:334-341
16. Pertovaara A, Kemppainen P, Leppanen H. Lowered cutaneous sensitivity to nonpainful electrical stimulation during isometric exercise in humans. Exp Brain Res 1992;89:447-452
17. Kosek E, Ekholm J, Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 1996;64:415-423
18. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-979
19. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965;206:9799
20. Kramis RC, Roberts WJ, Gillette RG. Non-nociceptive aspects of persistent musculoskeletal pain. J Orthop Sports Phys Ther 1996:24:255-267
21. Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol (Lond) 1984;356:443-458
22. Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G. Altered heat pain thresholds and cerebral event-related potentials following painful C02 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994;58:185-193
23. Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996:100:165-168
24. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input [published erratum appears in Pain 1993;52:251-253]. Pain 1992; 51:175-194
25. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afférents signal the hyperalgesia associated with nerve injury. Pain 1988:32:89-94
26. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993:20:1925-1931
27. Koltzenburg M, Kress M, Reeh PW. The nociceptor sensitization by bradykinin does not depend on sympathetic neurons. Neuroscience 1992;46:465-473
28. Torebjork HE, Lundberg LER, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 1992:448:765-780
29. Foreman RD, Kenshalo DR Jr, Schmidt RF, Willis WD. Field potentials and excitation of primate spinothalamic neurones in réponse to volleys in muscle afférents. J Physiol (Lond) 1979:286:197213
30. Guieu R, Serratrice G. Identifying the afférents involved in movement-induced pain alleviation in man. Brain 1992;115:1073-1079
31. Beric A. Central pain: new syndromes and their evaluation. Muscle Nerve 1993;16:1017-1024
32. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992;15:96-103
33. Desbiens NA, Wu AW, Alzola C, Mueller-Rizner N, Wenger NS, Connors AF Jr, et al (SUPPORT Investigators). Pain during hospitalization is associated with continued pain six months later in survivors of serious illness. Am J Med 1997;102:269-276
34. Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996;66:195-205
35. Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984;11:814-818
36. U r rows S, Affleck G, Tennen H, Higgins P. Unique clinical and psychological correlates of fibromyalgia tender points and joint tenderness in rheumatoid arthritis. Arthritis Rheum 1994:37:15131520
37. Borenstein D. Prevalence and treatment outcome of primary and secondary fibromyalgia in patients with spinal pain. Spine 1995; 20:796-800
38. Lapossy E, Maleitzke R, Hrycaj P, Mennet W, Muller W. The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995;24:29-33
39. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994:37:1181-1188
40. Morand EF, Miller MH, Whittingham S, Littlejohn GO. Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 1994;3:187-191
41. Buskila D, Neumann L, Valsberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury: a controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997; 40:446-452
42. Veale D, Kavanagh G, Fielding JF, Fitzgerald 0. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991;30:220-222
43. Wallace DJ. Genitourinary manifestations of fibrositis: an increased association with the female urethral syndrome. J Rheumatol 1990; 17:238-239
44. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 1996:312:1339
45. Dlnerman H, Steere AC. Fibromyalgia following Lyme disease: association with neurologic involvement and lack of response to antibiotic therapy [abstract]. Arthritis Rheum 1990;33(Suppl): S136
46. Slmms RW, Ferrante N, Craven DE (AIDS Clinical Research Team). High prevalence of fibromyalgia syndrome (FMS) in human immunodeficiency virus type l (HIV) infected patients with polyarthralgia [abstract]. Arthritis Rheum 1990;33(Suppl):S136
47. Rivera J, de Diego A, Trlnchet M, Garcia Monforte A. Fibromyalgiaassociated hepatitis C virus infection. Br J Rheumatol 1997:36:981-985
48. Barkhuizen A, Schoepflin GS, Bennett RM. Fibromyalgia: a prominent feature in patients with musculoskeletal problems in chronic hepatitis C; a report of 12 patients. J Clin Rheumatol 1996;2:180184
49. Leventhal U, Naides SJ, Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum 1991;34:1319-1324
50. Bennett R. The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 1997;6:494-499
51. Watklns LR, Maler SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995:63:289-302
52. Wiertelak EP, Furness LE, Horan R, Martinez J, Maier SF, Watkins LR. Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDA-nitric oxide cascade. Brain Res 1994:649:19-26
53. Wiertelak EP, Roemer B, Maier SF, Watkins LR. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res 1997;748:143-150
54. Watkins LR, Wiertelak EP, Goehler LE, Mooney-Heiberger K, Martinez J, Furness L, et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res 1994:639:283-299
55. DeLeo JA, Colburn RW, Nlchols M, Malhotra A. Interleukin 6 mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res 1996:16:695-700
56. Woolf CJ, Allchorne A, Safleh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997;121:417424
57. Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996:26:605611
58. Buskila D, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997;24:941-944
59. Dubner R. Hyperalgesia and expanded receptive fields [editorial]. Pain 1992:48:3-4
60. Dlckenson AH, Sullivan AF. NMDA receptors and central hyperalgesic states [letter]. Pain 1991;46:344-346
61. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991:44:293-299
62. BasbaumAI. Memories of pain. Sei Med 1996 Nov/Dec;3:22-31
63. De Felipe C, Herrero JF, O'Brlen JA, Palmer JA, Doyle CA, Smith AJ, et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998:392:394-397
64. Arnetz BB, Fjellner B. Psychological predictors of neuroendocrine responses to mental stress. J Psychosom Res 1986:30:297-305
65. Sastry BR. Substance P effects on spinal nociceptive neurones. Life Sei 1979;24:2169-2177
66. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-285
67. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997:386:721-724
68. Mantyh PW, DeMaster E, Malhotra A, Ghilardi JR, Rogers SO, Mantyh CR, et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995;268:1629-1632
69. Liu H, Brown JL, Jasmin L, Maggio JE, Vlgna SR, Mantyh PW, et al. Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Nail Acad Sei USA 1994;91:1009-1013
70. Tslgos C, Diemel LT, White A, Tomlinson DR, Young RJ. Cérébrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy. Clin Sei (Colch) 1993:84:305311
71. Vaeroy H, Helle R, Forre 0, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988:32:21-26
72. Russell IJ, Orr MD, Liftman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994:37:1593-1601
73. Watkins LR, Wiertelak EP, Furness LE, Maier SF. llness induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 1994;664:17-24
74. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, editors. Textbook of Pain. 3rd ed. Edinburgh: Churchill Livingstone; 1994. pp 245-257
75. Hohelsel U, Mense S. Response behaviour of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues. J Physiol (Lond) 1990:426:265-280
76. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7:309-338
77. Wall PD, Cronly-Dillon JR. Pain, itch, and vibration. Arch Neurol 1960:2:365-375
78. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997;13:189-196
79. Lenz FA, Gracely RH, Romanoski AJ, Hope EJ, Rowland LH, Dougherty PM. Stimulation in the human somatosensory thalamus can reproduce both the affective and sensory dimensions of previously experienced pain. Nat Med 1995:1:910-913
80. Davis KD, Kiss ZH, Luo L, Tasker RR, Lozano AM, Dostrovsky JO. Phantom sensations generated by thalamic microstimulation. Nature 1998:391:385-387
81. Pillay PK, Hassenbusch SJ. Bilateral MRI-guided stereotactic cingulotomy for intractable pain. Stereotact Funct Neurosurg 1992; 59:33-38
82. Foltz EL, White LE Jr. Pain relief by frontal cingulumotomy. J Neurosurg 1962; 19:89-100
83. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997;277:968-971
84. Devlnsky 0, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995:118:279-306
85. Hsieh JC, Beifrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995:63:225-236
86. Davis KD, Taylor SJ, Crawley AP, Wood ML, Mikulis DJ. Functional MRI of pain- and attention-related activations in the human cingulate cortex. J Neurophysiol 1997;77:3370-3380
87. Davis KD, Wood ML, Crawley AP, Mikulis DJ. fMRI of human somatosensory and cingulate cortex during painful electrical nerve stimulation. Neuroreport 1995:7:321-325
88. Jones AK. Pain, its perception, and imaging. MSP Newslett 1997 May/Jun;3-5
89. Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 1996:61:62-69
90. Cralg AD. A new version of the thalamic disinhibition hypothesis of central pain. Pain Forum 1998 Spring;7:l-14
91. Head H, Holmes G. Sensory disturbances from cerebral lesions. Brain 1911-1912:34:102-254
92. Di Piero V, Fiacco F, Tombari D, Pantano P. Tonic pain: a SPET study in normal subjects and cluster headache patients. Pain 1997;70:185-191
93. Pagni CA, Canavero S. Functional thalamic depression in a case of reversible central pain due to a spinal intramedullary cyst: case report. J Neumsurg 1995;83:163-165
94. Hirato M, Watanabe K, Takahashi A, Hayase N, Horikoshi S, Shibasaki T, et al. Pathophysiology of central (thalamic) pain: combined change of sensory thalamus with cerebral cortex around central sulcus. Stereotact Funct Neumsurg 1994;62:300303
95. Mountz JM, Bradley LA, Modell JG, Alexander RW, TrianaAlexander M, Aaron LA, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-938
96. Sakiyama Y, Sato A, Senda M, Ishiwata K, Toyama H, Schmidt RF. Positron emission tomography reveals changes in global and regional cerebral blood flow during noxious stimulation of normal and inflamed elbow joints in anesthetized cats. Exp Brain Res 1998:118:439-446
97. Xu X, Fukuyama H, Yazawa S, Mima T, Hanakawa T, Magata Y, et al. Functional localization of pain perception in the human brain studied by PET. Neuroreport 1997;8:555-559
98. Jones AK, Brown WD, Friston KJ, Qi LY, Frackowiak RS. Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc R Soc Lond B Biol Sei 1991; 244:39-44
99. ladarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, et al. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995;63:55-64
100. Turk DC, Okifuji A, Sinclair JD, Starz TW. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 1996:23:1255-1262
101. Toomey TC, Seville JL, Mann JD, Abashian SW, Grant JR. Relation ship of sexual and physical abuse to pain description, coping, psychological distress, and health-care utilization in a chronic pain sample. Clin J Pain 1995:11:307-315
102. Turk DC, Okifuji A, Starz TW, Sinclair JD. Effects of type of symptom onset on psychological distress and disability in fibromyalgia syndrome patients. Pain 1996;68:423-430
103. Bandura A. Self-efficacy mechanism in physiological activation and health-promoting behavior. In: Madden JIV, Matthysse S, Barchas J, editors. Adaption, Learning and Affect. New York: Raven Press; 1986
104. Amir M, Kaplan Z, Neumann L, Sharabani R, Shani N, Buskila D. Posttraumatic stress disorder, tenderness and fibromyalgia. J Psychosom Res 1997:42:607-613
105. Sigal LH. Illness behavior and the biomédical model. Bull Rheum Dis 1997 Feb;46:l-4
106. Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996:68:363-368
107. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with fibrositis syndrome and healthy subjects. Psychosom Med 1975:37:341-351
108. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976:38:35-44
109. Eccleston C, Crombez G, Aldrich S, Stannard C. Attention and somatic awareness in chronic pain. Pain 1997:72:209-215
110. Moldofsky H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin, and pain. AdvNeurol 1982;33:51-57
111. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994. pp 445-469
112. Matsuda S, Peng H, Yoshimura H, Wen TC, Fukuda T, Sakanaka M. Persistent c-fos expression in the brains of mice with chronic social stress. Neurosci Res 1996;26:157-170
113. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987;328:632634
114. Abbadie C, Besson JM. C-fos expression in rat lumbar spinal cord following peripheral stimulation in adjuvant-induced arthritic and normal rats. Brain Res 1993:607:195-204
115. Elliott KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995;61:401-409
116. Robbins JM, Kirmayer U, Hemami S. Latent variable models of functional somatic distress. J Nerv Ment Dis 1997;185:606-615
117. Turk DC, Okifuji A, Schärft L. Chronic pain and depression: role of perceived impact and perceived control in different age cohorts. Pain 1995:61:93-101
118. Krause SJ, Wiener RL, Tait RC. Depression and pain behavior in patients with chronic pain. Clin J Pain 1994;10:122-127
119. McWhinney IR, Epstein RM, Freeman TR. Rethinking somatization. Ann Intern Med 1997:126:747-750
120. King SA. Review: DSM-IV and pain. Clin J Pain 1995;11:171-176
121. Bennett RM. Confounding features of the fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol Suppl 1989:19:58-61
122. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990:33:160172
123. Deodhar AA, Fisher RA, Blacker CVR, Woolf AD. Fluid retention syndrome and fibromyalgia. Br J Rheumatol 1994;33:576-582
124. Weiss DJ, Kreck T, Albert RK. Dyspnea resulting from fibromyalgia. Chest 1998:113:246-249
125. Plesh 0, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol 1996:23:1948-1952
126. Pellegrino MJ. Atypical chest pain as an initial presentation of primary fibromyalgia. Arch Phys Med Rehabil 1990;71:526-528
127. Caidahl K, Lurie M, Bake B, Johansson G, Wetterqvist H. Dyspnoea in chronic primary fibromyalgia. J Intern Med 1989:226:265-270
128. Blasberg B, Chalmers A. Temporomandibular pain and dysfunction syndrome associated with generalized musculoskeletal pain: a retrospective study. J Rheumatol Suppl 1989:19:87-90
129. Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986:13:368-373
130. Gerster JC, Hadj-Djilani A. Hearing and vestibular abnormalities in primary fibrositis syndrome. J Rheumatol 1984;11:678-680
131. Burckhardt CS, O'Reilly CA, Wiens AN, Clark SR, Campbell SM, Bennett RM. Assessing depression in fibromyalgia patients. Arthritis Care Res 1994;7:35-39
132. Yunus M, Mas! AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-171
133. Bennett RM, Clark SR, Campbell SM, Ingram SB, Burckhardt CS, Nelson DL, et al. Symptoms of Raynaud's syndrome in patients with fibromyalgia: a study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet alpha 2-adrenergic receptors. Arthritis Rheum 1991:34:264-269
134. Sivri A, Cindas A, Dincer F, Sivri B. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol 1996; 15:283-286
135. Paira SO. Fibromyalgia associated with female urethral syndrome. Clin Rheumatol 1994:13:88-89
136. Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997;49(Suppl):52-57
137. Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J PsychiatrRes 1997;31:125-131
138. Bou-Holaigah I, Calkins H, Flynn JA, Tunin C, Chang HC, Kan JS, et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997:15:239-246
139. McDermid AJ, Rollman GB, McCain GA. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 1996; 66:133-144
140. Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996:39:436-445
141. Goldenberg DL. An overview of psychologic studies in fibromyalgia. J Rheumatol Suppl 1989:19:12-14
142. Katz RS, Kravitz HM. Fibromyalgia, depression, and alcoholism: a family history study. J Rheumata/ 1996;23:149-154
143. Kirmayer U, Robbins JM, Kapusta MA. Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 1988:145:950954
144. Hudson Jl, Pope HG Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of affective spectrum disorder? J Rheumatol Suppl 1989;19:15-22
145. Snow-Turek AL, Norris MP, Tan G. Active and passive coping strategies in chronic pain patients. Pain 1996;64:455-462
146. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983:17:33-44
147. Nicassio PM, Schoenfeld-Smith K, Radojevic V, Schuman C. Pain coping mechanisms in fibromyalgia: relationship to pain and functional outcomes. J Rheumatol 1995:22:1552-1558
148. Lisse JR. Rheumatic disorders in adults under 50: guidelines for differential diagnosis. Postgrad Med 1988 Oct;84:113-114; 119121
149. Pillemer SR, Bradley LA, Crofford U, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997;40:1928-1939
150. Crofford U, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:15831592
151. Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993:20:469-474
152. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992:35:1113-1116
153. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-l axis dysfunction in patients with fibromyalgia. J Rheumatol 1997:24:1384-1389
154. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992:37:387-397
155. Wallymahmed ME, Baker GA, Humphris G, Dewey M, MacFarlane IA. The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1996;44:403-411
156. Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Wiles CM, Hesp R, et al. Cardiovascular effects of growth hormone treatment in growthhormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sei (Colch) 1991:81:587-592
157. Rutherford OM, Beshyah SA, Schott J, Watkins Y, Johnston DG. Contractile properties of the quadriceps muscle in growth hormonedeficient hypopituitary adults. Clin Sei (Colch) 1995:88:67-71
158. McGauley GA, Cuneo RC, Salomon F, Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 1990;33(Suppl 4):5254
159. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N EnglJMed 1989:321:1797-1803
160. Florini JR. Hormonal control of muscle growth. Muscle Nerve 1987:10:577-598
161. Bennett RM. The contribution of muscle to the generation of fibromyalgia symptomatology. J Musculoskeletal Pain 1996;4(No. l/2):35-59
162. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998;104:227-231
163. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-153
164. Skuse D, Albanese A, Stanhope R, Gilmour J, Voss L. A new stressrelated syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency. Lancet 1996;348:353-358
165. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203217
166. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symptom Manage 1990;5(Suppl):S2-S5
167. Portenoy RK, Dole V, Joseph H, Lowinson J, Rice C, Segal S, et al. Pain management and chemical dependency: evolving perspectives. JAMA 1997;278:592-593
168. Melzack R. The tragedy of needless pain. Sei Am 1990 Feb;262: 27-33
169. Wall PD. The generation of yet another myth on the use of narcotics [editorial]. Pain 1997;73:121-122
170. Weissman DE, Haddox JD. Opioid pseudoaddiction: an iatrogenic syndrome. Pain 1989;36:363-366
171. Aronson MD. Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther 1997;19:420-432
172. Russell U, Kamin M, Sager D, Bennett RM, Schnitzer T, Green JA, et al. Efficacy of Ultram [tramadol HCL] treatment of fibromyalgia syndrome: preliminary analysis of a multi-center, randomized, placebo-controlled study [abstract]. Arthritis Rheum 1997;40(Suppl): S117
173. Roth SH. Efficacy and safety of tramadol HCI in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998:25:1358-1363
174. Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf 1996:15:8-29
175. Bias! G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998;18:13-19
176. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998:50:1842-1846
177. Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin North Am 1996 May;22:351-367
178. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995; 24:360-365
179. Sorensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997:24:1615-1621
180. Woolf CJ. A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization. Drugs 1994; 47(Suppl 5):l-9